Skip to content
Innovative Tech
Diseases
Health Policy
HTA
Data Analysis
Clinical Practice
Contributors
BACK TO MAIN SITE
Cost Savings on Generic Drugs: Transparent Pric...
By
HEOR Staff Writer
June 18, 2024
Introduction Through its transparent, online direct-to-consumer pharmacy model, the Mark Cuban Cost Plus Drug Company (MCCPDC) has made substantial progress in the provisi...
Brucellosis Control in Armenia: A Holistic Approach
Introducing GRACE for Patient-Centric Care
Universal Early Parenting Programmes: Unraveling the Cost-Effectiveness
The Economic Burden of Knee Arthroplasty Revisions: A Cost Analysis from Türkiye
Rethinking Health State Valuation: Moving Beyond ‘Dead’ as an Anchor
Enhancing Clinician Accuracy in EEG Pattern Classification with AI
Advancing Pneumococcal Disease Prevention in Japan with PCV20
Europe MedTech Sector: Opportunities and Challenges
The Impact of Time Horizons on QALY Calculations in Healthcare
Making Better Choices in Diabetes Care With Multi-criteria Decision Making (M...
Unveiling the Future of Personalised Sleep Medicine
Nurturing Trust in Healthcare: Embracing Generative AI
« Previous
1
…
46
47
48
49
50
…
81
Next »